ArticleFrontiers in immunology2024

MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular immune responses.

Patricia Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.